Vanguard Group’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$164M Sell
5,202,306
-3,136
-0.1% -$104K ﹤0.01% 1647
2025
Q3
$186M Sell
5,205,442
-42,630
-0.8% -$1.95M ﹤0.01% 1574
2025
Q2
$302M Buy
5,248,072
+120,935
+2% +$6.84M ﹤0.01% 1299
2025
Q1
$299M Sell
5,127,137
-13,289
-0.3% -$907K 0.01% 1274
2024
Q4
$414M Buy
5,140,426
+297,075
+6% +$25.4M 0.01% 1150
2024
Q3
$388M Buy
4,843,351
+131,204
+3% +$9.32M 0.01% 1192
2024
Q2
$288M Buy
4,712,147
+465,398
+11% +$27.7M 0.01% 1287
2024
Q1
$210M Buy
4,246,749
+62,164
+1% +$2.96M ﹤0.01% 1488
2023
Q4
$175M Buy
4,184,585
+109,694
+3% +$3.74M ﹤0.01% 1583
2023
Q3
$134M Buy
4,074,891
+385,271
+10% +$13.1M ﹤0.01% 1648
2023
Q2
$130M Buy
3,689,620
+420,850
+13% +$13.9M ﹤0.01% 1709
2023
Q1
$92.8M Buy
3,268,770
+33,906
+1% +$1.2M ﹤0.01% 1866
2022
Q4
$134M Buy
3,234,864
+396,340
+14% +$17M ﹤0.01% 1638
2022
Q3
$118M Buy
2,838,524
+381,894
+16% +$15.2M ﹤0.01% 1683
2022
Q2
$80.3M Buy
2,456,630
+1,848,617
+304% +$67.2M ﹤0.01% 1948
2022
Q1
$21.3M Buy
608,013
+23,439
+4% +$564K ﹤0.01% 2739
2021
Q4
$14.6M Buy
584,574
+128,780
+28% +$4.76M ﹤0.01% 3012
2021
Q3
$17.4M Buy
+455,794
New +$17.5M ﹤0.01% 2940

Other funds holding PRCT